Local cuisine emerges as the region's strongest dining force, as traditional restaurant settings give way to fluid, social spaces. SINGAPORE, Oct. 6, 2026 /PRNewswire/ -- Marriott International has unveiled Future of Food 2027, its latest report exploring food and beverage trends across Asia Pacific excluding China.

Refreshed accommodations, light-filled public spaces, and vibrant culinary debuts an enriched resort experience grounded in nature, play, and community. NAPLES, Fla.

Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) subsidiary Marea Therapeutics has dosed the first patient in a Phase 2 clinical trial of MAR002, a first-in-class antibody therapy for acromegaly, the company said on Monday.  Marea, which is developing medicines for cardioendocrine diseases, is advancing MAR002 as a potential new option for the rare endocrine disorder.

Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, compared to the daily subcutaneous injections required by the current standard of care

ETFs like AWAY are riding on "funflation" as consumers keep spending on hobbies, travel, music and leisure despite higher prices.

SOUTH SAN FRANCISCO and LIBERTY CORNER, N.J., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Marea Therapeutics, Inc. (“Marea”), a subsidiary of Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced that data from the Phase 2b TYDAL study of MAR001, a potential first-in-class monoclonal antibody targeting angiopoietin-like protein 4 (ANGPTL4), will be presented in a late-breaking science session at the American Heart Association (AHA) Scientific Sessions 2026, taking place November 6-9, 2026, in Chicago, Illinois.

Allworth Financial LP trimmed its holdings in Marriott International, Inc. (NASDAQ: MAR) by 39.6% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,976 shares of the company's stock after selling 9,812 shares during the period. Allworth Financial LP's holdings in Marriott

Marriott International, Inc. (MAR) Presents at Bank of America Gaming and Lodging Conference 2026 Transcript

Thoughtfully designed voyages across Europe balance iconic destinations with quieter coastal communities, creating space for unexpected moments of discovery along the way. FORT LAUDERDALE, Fla.

California State Teachers Retirement System lifted its position in Marriott International, Inc. (NASDAQ: MAR) by 43,255.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 114,540,104 shares of the company's stock after acquiring an additional 114,275,918 shares during the period. California